The Ave-Rec trial: Phase II trial of PDL1/PD-1 blockade with Avelumab post Chemoradiotherapy for locally advanced resectable T3B-4/N1-2 Rectal cancer.

已完结 20 由达姆发布于 2026/6/9 13:47:38

DOI:10.1158/1078-0432.ccr-25-0705
作者：Michael Michael,Rachel Wong,Sanjeev Gill,Andrew H Strickland,Nick Pavlakis,Jeremy D Shapiro,Emma Link,Maria Farrell,Samuel Y Ngan,Jeanne Tie,Alexander G Heriot,David Goldstein,Catherine Mitchell,Sara
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：PURPOSE Long course chemoradiotherapy (LCCRT) for locally advanced rectal cancer (LARC) results in 10-30% pathological complete response rate (pCR). Radiotherapy is both immuno-stimulatory

应助信息

1天前

你我没有ta

67f6e8d963c711f1bc2534735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/6/9 13:47:38 未找到该文献，机器人已退出，请等待人工下载

2026/6/9 13:47:38 Book学术AI机器人收到请求，开始寻找文献

2026/6/9 13:47:38 已向机器人发送请求

1天前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Physical Activity in Pediatric Inflammatory Bowel Disease: A Scoping Review.